- Arcutis Announces Appointment of Sue-Jean Lin to Board of Directors
06/09/2021 / 22:01 - GlobeNewswire
-
- Opthea Appoints Julia A. Haller, MD, and Judith Robertson to Board of Directors
06/01/2021 / 13:11 - GlobeNewswire
-
- Antares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer
04/26/2021 / 14:30 - GlobeNewswire
-
- Orasis Pharmaceuticals Appoints Industry Veteran, Paul Smith, as President and Chief Operating Officer to Lead the Next Phase of Growth
04/26/2021 / 14:00 - GlobeNewswire
-
- CIO Celebrates Emerging Technology with 2021 FutureEdge 50 Awards
04/12/2021 / 15:28 - GlobeNewswire
-
- OKYO Pharma Limited ("OKYO" or the "Company") - OKYO announces appointment of Dr Rajkumar Patil as Chief Scientific Officer
03/29/2021 / 08:00 - GlobeNewswire
-
- Ed TALKS Panel: Are we there, yet? Measuring effectiveness of InfoSec programs
03/22/2021 / 15:42 - GlobeNewswire
-
- project44 Unveils Supply Chain Visibility Conference Transform 2021
03/02/2021 / 15:00 - GlobeNewswire
-
- Ed TALKS Panel: SolariGate – Avoiding Supply Chain Burns
02/18/2021 / 16:15 - GlobeNewswire
-
- ProQR Announces Expert Perspectives Call on Disease Education and Endpoints in Usher Syndrome
02/16/2021 / 22:30 - GlobeNewswire
-
- UNITY Biotechnology Appoints Mike Sapieha, Ph.D., as Chief Scientific Advisor
02/01/2021 / 14:00 - GlobeNewswire
-
- Graybug Vision Appoints Bettina Maunz as Chief People Officer, Expanding the Company’s Executive Team
02/01/2021 / 13:30 - GlobeNewswire
-
- ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
12/22/2020 / 13:00 - GlobeNewswire
-
- project44 Raises $100M to Accelerate Supply Chain Transformation, Expand Advanced Visibility Platform
12/21/2020 / 15:00 - GlobeNewswire
-
- Oyster Point Pharma Strengthens Executive Leadership Team with the Appointment of Chief Medical and Chief Scientific Officers
12/07/2020 / 13:00 - GlobeNewswire
Real-time